Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil

AbstractBackgroundThe extent and profiles of heterogeneity in cognitive functioning among participants in clinical trials of antidementia medication are unknown. We aimed to quantify and identify profiles of heterogeneity of cognition in Alzheimer’s disease.MethodsIndividual-level participant data w...

Full description

Bibliographic Details
Main Authors: Stephen Z. Levine, Yair Goldberg, Kazufumi Yoshida, Myrto Samara, Andrea Cipriani, Takeshi Iwatsubo, Stefan Leucht, Toshiaki A. Furawaka
Format: Article
Language:English
Published: Cambridge University Press 2021-01-01
Series:European Psychiatry
Subjects:
Clinical trials
dementia
psychometrics
Online Access:https://www.cambridge.org/core/product/identifier/S0924933821000080/type/journal_article

Similar Items

Similar Items